Navigation Links
Research details how a virus hijacks cell signals to cause infection

A common virus that causes meningitis and heart inflammation takes a "back door" approach to evade natural barriers, then exploits biological signals to infect human cells. Broadening knowledge of how viruses cause infection, a new study describes elaborate methods that the virus has evolved to bypass the body's defenses.

"This study helps to explain how group B coxsackieviruses infect cells," said Jeffrey M. Bergelson, M.D., a pediatric infectious diseases specialist at The Children's Hospital of Philadelphia. "We found new steps in the virus life cycle."

Dr. Bergelson's study, co-authored with Carolyn B. Coyne, Ph.D., also of Children's Hospital, appears in the Jan. 13 issue of the journal Cell.

Group B coxsackieviruses (CVBs) are common in people, but usually are defeated by the immune system after causing minor infections. However, CVBs may sometimes cause myocarditis, a potentially severe inflammation of the heart in children and adults, as well as viral meningitis, which inflames the lining of the brain. Rarely, the virus may lead to fatal, overwhelming infection in newborns.

CVBs typically reach people in contaminated food or water, with the virus entering cells that line the intestine, called epithelial cells. Just how the virus enters those cells has been puzzling to scientists. Dr. Bergelson previously discovered a cell receptor called the coxsackievirus and adenovirus receptor (CAR) to which the virus attaches itself. However, the CAR remains below the surface of epithelial cells, in a seemingly inaccessible location called the tight junction.

In the new study, Drs. Bergelson and Coyne found that CVBs have evolved an indirect route of attack. The virus first attaches itself to more accessible cell receptors called DAF receptors that lie exposed on the upper surface of epithelial cells.

After attaching itself to a DAF receptor, the virus triggers two signals that open the door to infection. One signal causes
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism

Post Your Comments:
(Date:12/2/2009)... turns out that wearing a cap is good for you, at ...om the Johns Hopkins Engineering in Oncology Cente..." of thread-like fibers holds the cell,s nucleus, ...standing this cap,s influence on cell and nuclear ... the diagnosis and treatment of diseases such as c...
(Date:12/2/2009)... , REDWOOD CITY, Calif., Dec. 2 /PRNewswire/ -...entity and authentication solutions, today announc...its DigitalPersona biometric fingerprint technolog...rsona U.are.U® 4500HD offering allows point-o...ntify users so that specific transactions can be l...
(Date:12/2/2009)...York, NY, December 2, 2009 Commonly prescribed be... asthma in pregnant women as well as pre-term labo...sorders, psychiatric pathology, cognitive problems...cording to a new study published in the December 2... Gynecology . , Beta 2 adrenergic agonist drugs ...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Winner Medical Schedules 2008 2009 Third Quarter Earnings Release on Tuesday August 11 2009 53833 1Winner Medical Schedules 2008 2009 Third Quarter Earnings Release on Tuesday August 11 2009 53833 2Former Microsoft Healthcare Executive Joins iMedExchange 53828 1Former Microsoft Healthcare Executive Joins iMedExchange 53828 2Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 1Shamir Optical Industry Ltd to Host Conference Call Announcing Second Quarter of 2009 Earnings Results 53823 2
...er bees, wasps, and ants are often considered neut...ies, who although unable to mate, can lay unfertil...e species, such as bumble bees, this is the source...s, like the honeybee, workers "police" each other ...aying workers. , In 1964 the English biologist W...
...m from a West Indian tarantula has been shown to c... that sense high temperatures and the hot, spicy i...iscovered. , The findings demonstrate that some pl...trategy to deter predators -- triggering pain by a...he research provides new tools to understand how t...
...splanted neural stem cells hold promise for reduci...rs in Parkinson’s disease and for replacing cells ...ublished in the current issue of The Journal of Ne...nt essentially enables an animal model for Parkins...displaying the progressive loss of movement contro...
Other Biology News:Why do some queen bees eat their worker bee's eggs? 2Tarantula venom and chili peppers target same pain sensor 2Transplanted brain cells hold promise for Parkinson's disease 2Transplanted brain cells hold promise for Parkinson's disease 3
(Date:12/2/2009)... , , QUEBEC CITY, Dec. 2 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced that the U.S. Food and Drug Adm...on for the Company,s PI3K/Akt pathway inhibitor co...f relapsed/refractory multiple myeloma. Keryx Biop...
(Date:12/2/2009)... , , HOBOKEN, N.J., Dec. 2 /PRNewswire/ ...40 percent to 45 percent of Americans diagnosed wi...tinopathy. Diabetic retinopathy, damage to the re...se of blindness in people with diabetes and is one...ct, up to 80 percent of all patients who,ve had di...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,.../www.reportlinker.com/p0164494/Chromium---Global-M...mium is primarily influenced by stainless steel, w...e markets is also important for growth of chromium...
(Date:12/1/2009)... , , PLYMOUTH, Mass., Dec. 1 /PRNewswire/...om ) announced today results from the company spon...amachandra Medical Center in Chennai, India using ...on-reconstructable Critical Limb Ischemia (CLI). S... international-associated institution based in Che...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...Q4 2007 sales increased 78.8% compared to Q4 2006 ...d to Q3 2007 -- Estimated sales for FY ... YORK, March 5 /Xinhua-PRNewswire-FirstCall/ -- Ch...d: CYXI), a leading provider in the,nutraceutical ...nd,distribution of organic nutritional food produc...
...LS, Mass., March 5 Joseph F. Finn, Jr.,CPA, the A...cs, confirmed,today that the sale of ActivBiotics,...sealed bid at 12:00 PM on March 14, 2008. There ha...bout different aspects of the,technology. "With 48...tion,to comprehensive due diligence, I believe we,...
...anagement Changes Announced, NEW YORK, March 5 B...nounced that the company,s Board of Directors,has ...hief financial,officer, effective March 31, 2008. ...ecting and managing the company,s fiscal operation...he organization and its,subsidiaries. Andrew Bonfi...
Other Biology Technology:China Yingxia International Announces Q4 and FY 2007 Estimates 2China Yingxia International Announces Q4 and FY 2007 Estimates 3Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 2Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 3
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Mouse Anti-Human Cystatin F Monoclonal Antibodies, 292103 from R&D Systems
Biology Products: